Business News • PR NewsWire • Distinguished Cancer Investigator, Daniel Von Hoff, M.D., to Lead Cell Therapeutics' Scientific Advisory Board |
Distinguished Cancer Investigator, Daniel Von Hoff, M.D., to Lead Cell Therapeutics' Scientific Advisory Board |
|
|
Distinguished Cancer Investigator, Daniel Von Hoff, M.D., to Lead Cell Therapeutics' Scientific Advisory Board
SEATTLE, July 24, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that Daniel D. Von Hoff, M.D., F.A.C.P, a leading medical oncologist who has been the lead investigator in the development of important oncology therapeutics, will serve...
View More : http://www.prnewswire.com/news-releases/distinguished-cancer-investigator-daniel-von-hoff-md-to-lead-cell-therapeutics-s...
|
|
|